nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocortisone—ABCB1—melanoma	0.179	1	CbGaD
Hydrocortisone—ABCG2—Vemurafenib—melanoma	0.138	0.267	CbGbCtD
Hydrocortisone—ABCG2—Dactinomycin—melanoma	0.0914	0.177	CbGbCtD
Hydrocortisone—CYP3A4—Temozolomide—melanoma	0.0542	0.105	CbGbCtD
Hydrocortisone—ABCG2—Docetaxel—melanoma	0.0472	0.0914	CbGbCtD
Hydrocortisone—CYP3A7—Docetaxel—melanoma	0.0348	0.0675	CbGbCtD
Hydrocortisone—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0348	0.0675	CbGbCtD
Hydrocortisone—ABCB1—Dactinomycin—melanoma	0.033	0.0639	CbGbCtD
Hydrocortisone—CYP3A4—Vemurafenib—melanoma	0.0297	0.0576	CbGbCtD
Hydrocortisone—CYP3A5—Docetaxel—melanoma	0.0261	0.0507	CbGbCtD
Hydrocortisone—ABCB1—Docetaxel—melanoma	0.017	0.033	CbGbCtD
Hydrocortisone—CYP3A4—Docetaxel—melanoma	0.0102	0.0198	CbGbCtD
Hydrocortisone—SHBG—hindlimb—melanoma	0.00151	0.182	CbGeAlD
Hydrocortisone—ANXA1—hair follicle—melanoma	0.00115	0.139	CbGeAlD
Hydrocortisone—ANXA1—neck—melanoma	0.000772	0.0931	CbGeAlD
Hydrocortisone—Malnutrition—Vemurafenib—melanoma	0.000677	0.00469	CcSEcCtD
Hydrocortisone—Erythema—Vemurafenib—melanoma	0.000677	0.00469	CcSEcCtD
Hydrocortisone—Testosterone Propionate—CYP17A1—melanoma	0.000672	0.167	CrCbGaD
Hydrocortisone—Necrosis—Docetaxel—melanoma	0.00067	0.00465	CcSEcCtD
Hydrocortisone—Thrombophlebitis—Temozolomide—melanoma	0.000664	0.0046	CcSEcCtD
Hydrocortisone—Lethargy—Dactinomycin—melanoma	0.000648	0.00449	CcSEcCtD
Hydrocortisone—Gastroenteritis—Temozolomide—melanoma	0.000648	0.00449	CcSEcCtD
Hydrocortisone—Injury—Carmustine—melanoma	0.000647	0.00448	CcSEcCtD
Hydrocortisone—Amenorrhoea—Docetaxel—melanoma	0.000599	0.00415	CcSEcCtD
Hydrocortisone—Myalgia—Vemurafenib—melanoma	0.000576	0.00399	CcSEcCtD
Hydrocortisone—ANXA1—eye—melanoma	0.000574	0.0692	CbGeAlD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000572	0.00397	CcSEcCtD
Hydrocortisone—Affect lability—Temozolomide—melanoma	0.000565	0.00392	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Vemurafenib—melanoma	0.000552	0.00383	CcSEcCtD
Hydrocortisone—Infection—Vemurafenib—melanoma	0.000549	0.0038	CcSEcCtD
Hydrocortisone—Mood swings—Temozolomide—melanoma	0.000544	0.00377	CcSEcCtD
Hydrocortisone—Inflammation—Docetaxel—melanoma	0.000543	0.00376	CcSEcCtD
Hydrocortisone—Nervous system disorder—Vemurafenib—melanoma	0.000542	0.00375	CcSEcCtD
Hydrocortisone—Hypokalaemia—Carmustine—melanoma	0.000541	0.00375	CcSEcCtD
Hydrocortisone—Skin disorder—Vemurafenib—melanoma	0.000537	0.00372	CcSEcCtD
Hydrocortisone—Weight decreased—Bleomycin—melanoma	0.000532	0.00369	CcSEcCtD
Hydrocortisone—Dry skin—Temozolomide—melanoma	0.000527	0.00365	CcSEcCtD
Hydrocortisone—Muscular weakness—Carmustine—melanoma	0.000524	0.00363	CcSEcCtD
Hydrocortisone—Hypokalaemia—Temozolomide—melanoma	0.000523	0.00362	CcSEcCtD
Hydrocortisone—Acute coronary syndrome—Bleomycin—melanoma	0.000517	0.00359	CcSEcCtD
Hydrocortisone—Hypotension—Vemurafenib—melanoma	0.000516	0.00358	CcSEcCtD
Hydrocortisone—SHBG—neck—melanoma	0.000516	0.0622	CbGeAlD
Hydrocortisone—Myocardial infarction—Bleomycin—melanoma	0.000514	0.00356	CcSEcCtD
Hydrocortisone—Muscular weakness—Temozolomide—melanoma	0.000507	0.00351	CcSEcCtD
Hydrocortisone—Alanine aminotransferase increased—Temozolomide—melanoma	0.000507	0.00351	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000503	0.00349	CcSEcCtD
Hydrocortisone—Skin exfoliation—Docetaxel—melanoma	0.000502	0.00348	CcSEcCtD
Hydrocortisone—Abdominal distension—Temozolomide—melanoma	0.0005	0.00346	CcSEcCtD
Hydrocortisone—ANXA1—skin of body—melanoma	0.0005	0.0602	CbGeAlD
Hydrocortisone—Fluid retention—Docetaxel—melanoma	0.0005	0.00346	CcSEcCtD
Hydrocortisone—Neuropathy—Docetaxel—melanoma	0.000494	0.00342	CcSEcCtD
Hydrocortisone—Sweating increased—Temozolomide—melanoma	0.000484	0.00335	CcSEcCtD
Hydrocortisone—Oesophagitis—Docetaxel—melanoma	0.000481	0.00333	CcSEcCtD
Hydrocortisone—Decreased appetite—Vemurafenib—melanoma	0.00048	0.00333	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Vemurafenib—melanoma	0.000477	0.00331	CcSEcCtD
Hydrocortisone—Fatigue—Vemurafenib—melanoma	0.000476	0.0033	CcSEcCtD
Hydrocortisone—Haemoglobin—Bleomycin—melanoma	0.000473	0.00328	CcSEcCtD
Hydrocortisone—Haemorrhage—Bleomycin—melanoma	0.000471	0.00326	CcSEcCtD
Hydrocortisone—Pulmonary oedema—Docetaxel—melanoma	0.000468	0.00325	CcSEcCtD
Hydrocortisone—Upper respiratory tract infection—Temozolomide—melanoma	0.000461	0.0032	CcSEcCtD
Hydrocortisone—ANXA1—mammalian vulva—melanoma	0.000456	0.0549	CbGeAlD
Hydrocortisone—Weight increased—Temozolomide—melanoma	0.000452	0.00313	CcSEcCtD
Hydrocortisone—Weight decreased—Temozolomide—melanoma	0.000449	0.00311	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Carmustine—melanoma	0.000449	0.00311	CcSEcCtD
Hydrocortisone—Infestation NOS—Temozolomide—melanoma	0.000443	0.00307	CcSEcCtD
Hydrocortisone—Infestation—Temozolomide—melanoma	0.000443	0.00307	CcSEcCtD
Hydrocortisone—Thrombophlebitis—Docetaxel—melanoma	0.000441	0.00306	CcSEcCtD
Hydrocortisone—Body temperature increased—Vemurafenib—melanoma	0.000437	0.00303	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Temozolomide—melanoma	0.000434	0.00301	CcSEcCtD
Hydrocortisone—Cardiac failure congestive—Docetaxel—melanoma	0.000421	0.00292	CcSEcCtD
Hydrocortisone—Haemoglobin—Carmustine—melanoma	0.000413	0.00286	CcSEcCtD
Hydrocortisone—Haemorrhage—Carmustine—melanoma	0.000411	0.00285	CcSEcCtD
Hydrocortisone—Erythema—Bleomycin—melanoma	0.00041	0.00284	CcSEcCtD
Hydrocortisone—Hallucination—Carmustine—melanoma	0.000409	0.00284	CcSEcCtD
Hydrocortisone—Hypersensitivity—Vemurafenib—melanoma	0.000407	0.00282	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Carmustine—melanoma	0.000404	0.0028	CcSEcCtD
Hydrocortisone—Haemoglobin—Temozolomide—melanoma	0.000399	0.00277	CcSEcCtD
Hydrocortisone—Haemorrhage—Temozolomide—melanoma	0.000397	0.00275	CcSEcCtD
Hydrocortisone—Asthenia—Vemurafenib—melanoma	0.000396	0.00275	CcSEcCtD
Hydrocortisone—Hallucination—Temozolomide—melanoma	0.000395	0.00274	CcSEcCtD
Hydrocortisone—Cardiac failure—Docetaxel—melanoma	0.000391	0.00271	CcSEcCtD
Hydrocortisone—Pruritus—Vemurafenib—melanoma	0.000391	0.00271	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Temozolomide—melanoma	0.000391	0.00271	CcSEcCtD
Hydrocortisone—Lethargy—Docetaxel—melanoma	0.00039	0.0027	CcSEcCtD
Hydrocortisone—Eye disorder—Carmustine—melanoma	0.000384	0.00266	CcSEcCtD
Hydrocortisone—Erythema—Dactinomycin—melanoma	0.000382	0.00265	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Bleomycin—melanoma	0.000381	0.00264	CcSEcCtD
Hydrocortisone—Diarrhoea—Vemurafenib—melanoma	0.000378	0.00262	CcSEcCtD
Hydrocortisone—Eye disorder—Temozolomide—melanoma	0.000371	0.00257	CcSEcCtD
Hydrocortisone—Malaise—Bleomycin—melanoma	0.00037	0.00256	CcSEcCtD
Hydrocortisone—Arrhythmia—Carmustine—melanoma	0.000367	0.00255	CcSEcCtD
Hydrocortisone—Dizziness—Vemurafenib—melanoma	0.000365	0.00253	CcSEcCtD
Hydrocortisone—Mental disorder—Carmustine—melanoma	0.00036	0.0025	CcSEcCtD
Hydrocortisone—Immune system disorder—Temozolomide—melanoma	0.000359	0.00249	CcSEcCtD
Hydrocortisone—Malnutrition—Carmustine—melanoma	0.000358	0.00248	CcSEcCtD
Hydrocortisone—Erythema—Carmustine—melanoma	0.000358	0.00248	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Dactinomycin—melanoma	0.000355	0.00246	CcSEcCtD
Hydrocortisone—Vomiting—Vemurafenib—melanoma	0.000351	0.00243	CcSEcCtD
Hydrocortisone—Dry skin—Docetaxel—melanoma	0.00035	0.00243	CcSEcCtD
Hydrocortisone—Myalgia—Bleomycin—melanoma	0.000349	0.00242	CcSEcCtD
Hydrocortisone—Abdominal pain upper—Docetaxel—melanoma	0.000349	0.00242	CcSEcCtD
Hydrocortisone—Rash—Vemurafenib—melanoma	0.000348	0.00241	CcSEcCtD
Hydrocortisone—Mental disorder—Temozolomide—melanoma	0.000348	0.00241	CcSEcCtD
Hydrocortisone—Dermatitis—Vemurafenib—melanoma	0.000348	0.00241	CcSEcCtD
Hydrocortisone—Headache—Vemurafenib—melanoma	0.000346	0.0024	CcSEcCtD
Hydrocortisone—Erythema—Temozolomide—melanoma	0.000346	0.0024	CcSEcCtD
Hydrocortisone—Malnutrition—Temozolomide—melanoma	0.000346	0.0024	CcSEcCtD
Hydrocortisone—Discomfort—Bleomycin—melanoma	0.000345	0.00239	CcSEcCtD
Hydrocortisone—Malaise—Dactinomycin—melanoma	0.000345	0.00239	CcSEcCtD
Hydrocortisone—Alanine aminotransferase increased—Docetaxel—melanoma	0.000337	0.00233	CcSEcCtD
Hydrocortisone—CYP11B2—lymph node—melanoma	0.000335	0.0404	CbGeAlD
Hydrocortisone—Oedema—Bleomycin—melanoma	0.000335	0.00232	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Bleomycin—melanoma	0.000335	0.00232	CcSEcCtD
Hydrocortisone—Infection—Bleomycin—melanoma	0.000333	0.0023	CcSEcCtD
Hydrocortisone—Nausea—Vemurafenib—melanoma	0.000328	0.00227	CcSEcCtD
Hydrocortisone—ANXA1—head—melanoma	0.000326	0.0393	CbGeAlD
Hydrocortisone—Myalgia—Dactinomycin—melanoma	0.000326	0.00226	CcSEcCtD
Hydrocortisone—Discomfort—Dactinomycin—melanoma	0.000322	0.00223	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Temozolomide—melanoma	0.000321	0.00222	CcSEcCtD
Hydrocortisone—Anorexia—Bleomycin—melanoma	0.000319	0.00221	CcSEcCtD
Hydrocortisone—Angioedema—Temozolomide—melanoma	0.000316	0.00219	CcSEcCtD
Hydrocortisone—Hypotension—Bleomycin—melanoma	0.000313	0.00217	CcSEcCtD
Hydrocortisone—Oedema—Dactinomycin—melanoma	0.000312	0.00216	CcSEcCtD
Hydrocortisone—Malaise—Temozolomide—melanoma	0.000312	0.00216	CcSEcCtD
Hydrocortisone—Vertigo—Temozolomide—melanoma	0.000311	0.00215	CcSEcCtD
Hydrocortisone—Convulsion—Carmustine—melanoma	0.00031	0.00215	CcSEcCtD
Hydrocortisone—Infection—Dactinomycin—melanoma	0.00031	0.00215	CcSEcCtD
Hydrocortisone—Hypertension—Carmustine—melanoma	0.000309	0.00214	CcSEcCtD
Hydrocortisone—Progesterone—CYP17A1—melanoma	0.000309	0.0768	CrCbGaD
Hydrocortisone—Musculoskeletal discomfort—Bleomycin—melanoma	0.000305	0.00211	CcSEcCtD
Hydrocortisone—Myalgia—Carmustine—melanoma	0.000305	0.00211	CcSEcCtD
Hydrocortisone—Anxiety—Carmustine—melanoma	0.000304	0.0021	CcSEcCtD
Hydrocortisone—Paraesthesia—Bleomycin—melanoma	0.000301	0.00208	CcSEcCtD
Hydrocortisone—Weight increased—Docetaxel—melanoma	0.0003	0.00208	CcSEcCtD
Hydrocortisone—Convulsion—Temozolomide—melanoma	0.0003	0.00208	CcSEcCtD
Hydrocortisone—Weight decreased—Docetaxel—melanoma	0.000299	0.00207	CcSEcCtD
Hydrocortisone—Hypertension—Temozolomide—melanoma	0.000299	0.00207	CcSEcCtD
Hydrocortisone—Anorexia—Dactinomycin—melanoma	0.000298	0.00206	CcSEcCtD
Hydrocortisone—Myalgia—Temozolomide—melanoma	0.000295	0.00204	CcSEcCtD
Hydrocortisone—Infestation NOS—Docetaxel—melanoma	0.000294	0.00204	CcSEcCtD
Hydrocortisone—Infestation—Docetaxel—melanoma	0.000294	0.00204	CcSEcCtD
Hydrocortisone—Anxiety—Temozolomide—melanoma	0.000293	0.00203	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000292	0.00203	CcSEcCtD
Hydrocortisone—Oedema—Carmustine—melanoma	0.000292	0.00202	CcSEcCtD
Hydrocortisone—Discomfort—Temozolomide—melanoma	0.000291	0.00202	CcSEcCtD
Hydrocortisone—Decreased appetite—Bleomycin—melanoma	0.000291	0.00202	CcSEcCtD
Hydrocortisone—Infection—Carmustine—melanoma	0.00029	0.00201	CcSEcCtD
Hydrocortisone—Acute coronary syndrome—Docetaxel—melanoma	0.00029	0.00201	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Docetaxel—melanoma	0.000289	0.002	CcSEcCtD
Hydrocortisone—Myocardial infarction—Docetaxel—melanoma	0.000289	0.002	CcSEcCtD
Hydrocortisone—Pain—Bleomycin—melanoma	0.000286	0.00198	CcSEcCtD
Hydrocortisone—Tachycardia—Carmustine—melanoma	0.000285	0.00198	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000284	0.00197	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Temozolomide—melanoma	0.000282	0.00196	CcSEcCtD
Hydrocortisone—Oedema—Temozolomide—melanoma	0.000282	0.00196	CcSEcCtD
Hydrocortisone—Dexamethasone—CYP17A1—melanoma	0.000282	0.0703	CrCbGaD
Hydrocortisone—Infection—Temozolomide—melanoma	0.00028	0.00194	CcSEcCtD
Hydrocortisone—Anorexia—Carmustine—melanoma	0.000278	0.00193	CcSEcCtD
Hydrocortisone—Nervous system disorder—Temozolomide—melanoma	0.000277	0.00192	CcSEcCtD
Hydrocortisone—Feeling abnormal—Bleomycin—melanoma	0.000276	0.00191	CcSEcCtD
Hydrocortisone—Skin disorder—Temozolomide—melanoma	0.000274	0.0019	CcSEcCtD
Hydrocortisone—Hypotension—Carmustine—melanoma	0.000273	0.00189	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Temozolomide—melanoma	0.000273	0.00189	CcSEcCtD
Hydrocortisone—Decreased appetite—Dactinomycin—melanoma	0.000271	0.00188	CcSEcCtD
Hydrocortisone—Fatigue—Dactinomycin—melanoma	0.000269	0.00187	CcSEcCtD
Hydrocortisone—Anorexia—Temozolomide—melanoma	0.000269	0.00187	CcSEcCtD
Hydrocortisone—NR3C1—neck—melanoma	0.000268	0.0323	CbGeAlD
Hydrocortisone—Pain—Dactinomycin—melanoma	0.000267	0.00185	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Carmustine—melanoma	0.000266	0.00184	CcSEcCtD
Hydrocortisone—Urticaria—Bleomycin—melanoma	0.000266	0.00184	CcSEcCtD
Hydrocortisone—Haemoglobin—Docetaxel—melanoma	0.000266	0.00184	CcSEcCtD
Hydrocortisone—Body temperature increased—Bleomycin—melanoma	0.000265	0.00183	CcSEcCtD
Hydrocortisone—Haemorrhage—Docetaxel—melanoma	0.000264	0.00183	CcSEcCtD
Hydrocortisone—Insomnia—Carmustine—melanoma	0.000264	0.00183	CcSEcCtD
Hydrocortisone—Paraesthesia—Carmustine—melanoma	0.000262	0.00182	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Docetaxel—melanoma	0.00026	0.0018	CcSEcCtD
Hydrocortisone—Feeling abnormal—Dactinomycin—melanoma	0.000257	0.00178	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Temozolomide—melanoma	0.000257	0.00178	CcSEcCtD
Hydrocortisone—Insomnia—Temozolomide—melanoma	0.000255	0.00177	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Dactinomycin—melanoma	0.000255	0.00177	CcSEcCtD
Hydrocortisone—Decreased appetite—Carmustine—melanoma	0.000254	0.00176	CcSEcCtD
Hydrocortisone—Paraesthesia—Temozolomide—melanoma	0.000254	0.00176	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Carmustine—melanoma	0.000252	0.00175	CcSEcCtD
Hydrocortisone—Pain—Carmustine—melanoma	0.00025	0.00173	CcSEcCtD
Hydrocortisone—Dyspepsia—Temozolomide—melanoma	0.000249	0.00172	CcSEcCtD
Hydrocortisone—Eye disorder—Docetaxel—melanoma	0.000247	0.00171	CcSEcCtD
Hydrocortisone—Abdominal pain—Dactinomycin—melanoma	0.000247	0.00171	CcSEcCtD
Hydrocortisone—Body temperature increased—Dactinomycin—melanoma	0.000247	0.00171	CcSEcCtD
Hydrocortisone—Hypersensitivity—Bleomycin—melanoma	0.000247	0.00171	CcSEcCtD
Hydrocortisone—Decreased appetite—Temozolomide—melanoma	0.000245	0.0017	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Temozolomide—melanoma	0.000244	0.00169	CcSEcCtD
Hydrocortisone—Fatigue—Temozolomide—melanoma	0.000243	0.00169	CcSEcCtD
Hydrocortisone—Pain—Temozolomide—melanoma	0.000241	0.00167	CcSEcCtD
Hydrocortisone—Feeling abnormal—Carmustine—melanoma	0.000241	0.00167	CcSEcCtD
Hydrocortisone—Asthenia—Bleomycin—melanoma	0.00024	0.00166	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Carmustine—melanoma	0.000239	0.00166	CcSEcCtD
Hydrocortisone—Immune system disorder—Docetaxel—melanoma	0.000239	0.00165	CcSEcCtD
Hydrocortisone—Pruritus—Bleomycin—melanoma	0.000237	0.00164	CcSEcCtD
Hydrocortisone—Arrhythmia—Docetaxel—melanoma	0.000236	0.00164	CcSEcCtD
Hydrocortisone—Feeling abnormal—Temozolomide—melanoma	0.000233	0.00161	CcSEcCtD
Hydrocortisone—Mental disorder—Docetaxel—melanoma	0.000232	0.0016	CcSEcCtD
Hydrocortisone—Abdominal pain—Carmustine—melanoma	0.000231	0.0016	CcSEcCtD
Hydrocortisone—Body temperature increased—Carmustine—melanoma	0.000231	0.0016	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Temozolomide—melanoma	0.000231	0.0016	CcSEcCtD
Hydrocortisone—Erythema—Docetaxel—melanoma	0.00023	0.00159	CcSEcCtD
Hydrocortisone—Malnutrition—Docetaxel—melanoma	0.00023	0.00159	CcSEcCtD
Hydrocortisone—Dexamethasone—NOS2—melanoma	0.00023	0.0573	CrCbGaD
Hydrocortisone—Hypersensitivity—Dactinomycin—melanoma	0.00023	0.00159	CcSEcCtD
Hydrocortisone—ANXA1—lymph node—melanoma	0.000228	0.0275	CbGeAlD
Hydrocortisone—Urticaria—Temozolomide—melanoma	0.000224	0.00155	CcSEcCtD
Hydrocortisone—Asthenia—Dactinomycin—melanoma	0.000224	0.00155	CcSEcCtD
Hydrocortisone—Abdominal pain—Temozolomide—melanoma	0.000223	0.00155	CcSEcCtD
Hydrocortisone—Body temperature increased—Temozolomide—melanoma	0.000223	0.00155	CcSEcCtD
Hydrocortisone—Hypersensitivity—Carmustine—melanoma	0.000215	0.00149	CcSEcCtD
Hydrocortisone—Progesterone—CYP1B1—melanoma	0.000214	0.0533	CrCbGaD
Hydrocortisone—Diarrhoea—Dactinomycin—melanoma	0.000214	0.00148	CcSEcCtD
Hydrocortisone—Vomiting—Bleomycin—melanoma	0.000213	0.00147	CcSEcCtD
Hydrocortisone—Rash—Bleomycin—melanoma	0.000211	0.00146	CcSEcCtD
Hydrocortisone—Dermatitis—Bleomycin—melanoma	0.000211	0.00146	CcSEcCtD
Hydrocortisone—Asthenia—Carmustine—melanoma	0.00021	0.00145	CcSEcCtD
Hydrocortisone—Hypersensitivity—Temozolomide—melanoma	0.000208	0.00144	CcSEcCtD
Hydrocortisone—Syncope—Docetaxel—melanoma	0.000206	0.00143	CcSEcCtD
Hydrocortisone—Asthenia—Temozolomide—melanoma	0.000203	0.0014	CcSEcCtD
Hydrocortisone—Loss of consciousness—Docetaxel—melanoma	0.000202	0.0014	CcSEcCtD
Hydrocortisone—Testosterone—CYP1B1—melanoma	0.000202	0.0503	CrCbGaD
Hydrocortisone—ABCB1—blood vessel—melanoma	0.000201	0.0242	CbGeAlD
Hydrocortisone—Diarrhoea—Carmustine—melanoma	0.0002	0.00139	CcSEcCtD
Hydrocortisone—Pruritus—Temozolomide—melanoma	0.0002	0.00138	CcSEcCtD
Hydrocortisone—NR3C1—eye—melanoma	0.000199	0.0241	CbGeAlD
Hydrocortisone—Convulsion—Docetaxel—melanoma	0.000199	0.00138	CcSEcCtD
Hydrocortisone—Nausea—Bleomycin—melanoma	0.000199	0.00138	CcSEcCtD
Hydrocortisone—Hypertension—Docetaxel—melanoma	0.000199	0.00138	CcSEcCtD
Hydrocortisone—Vomiting—Dactinomycin—melanoma	0.000198	0.00138	CcSEcCtD
Hydrocortisone—Rash—Dactinomycin—melanoma	0.000197	0.00136	CcSEcCtD
Hydrocortisone—Myalgia—Docetaxel—melanoma	0.000196	0.00136	CcSEcCtD
Hydrocortisone—Dexamethasone—CYP1B1—melanoma	0.000196	0.0487	CrCbGaD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000195	0.00135	CcSEcCtD
Hydrocortisone—Dizziness—Carmustine—melanoma	0.000193	0.00134	CcSEcCtD
Hydrocortisone—Diarrhoea—Temozolomide—melanoma	0.000193	0.00134	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Docetaxel—melanoma	0.000188	0.0013	CcSEcCtD
Hydrocortisone—Oedema—Docetaxel—melanoma	0.000188	0.0013	CcSEcCtD
Hydrocortisone—Drospirenone—PTGS2—melanoma	0.000187	0.0466	CrCbGaD
Hydrocortisone—Dizziness—Temozolomide—melanoma	0.000187	0.00129	CcSEcCtD
Hydrocortisone—Infection—Docetaxel—melanoma	0.000187	0.00129	CcSEcCtD
Hydrocortisone—Vomiting—Carmustine—melanoma	0.000186	0.00129	CcSEcCtD
Hydrocortisone—Nausea—Dactinomycin—melanoma	0.000185	0.00128	CcSEcCtD
Hydrocortisone—Shock—Docetaxel—melanoma	0.000185	0.00128	CcSEcCtD
Hydrocortisone—Rash—Carmustine—melanoma	0.000184	0.00128	CcSEcCtD
Hydrocortisone—Nervous system disorder—Docetaxel—melanoma	0.000184	0.00128	CcSEcCtD
Hydrocortisone—Dermatitis—Carmustine—melanoma	0.000184	0.00128	CcSEcCtD
Hydrocortisone—Tachycardia—Docetaxel—melanoma	0.000183	0.00127	CcSEcCtD
Hydrocortisone—Headache—Carmustine—melanoma	0.000183	0.00127	CcSEcCtD
Hydrocortisone—Megestrol acetate—ABCB1—melanoma	0.000182	0.0454	CrCbGaD
Hydrocortisone—Skin disorder—Docetaxel—melanoma	0.000182	0.00126	CcSEcCtD
Hydrocortisone—SLCO1A2—head—melanoma	0.000181	0.0218	CbGeAlD
Hydrocortisone—Vomiting—Temozolomide—melanoma	0.00018	0.00124	CcSEcCtD
Hydrocortisone—Anorexia—Docetaxel—melanoma	0.000179	0.00124	CcSEcCtD
Hydrocortisone—Rash—Temozolomide—melanoma	0.000178	0.00123	CcSEcCtD
Hydrocortisone—Dermatitis—Temozolomide—melanoma	0.000178	0.00123	CcSEcCtD
Hydrocortisone—Headache—Temozolomide—melanoma	0.000177	0.00123	CcSEcCtD
Hydrocortisone—Hypotension—Docetaxel—melanoma	0.000175	0.00122	CcSEcCtD
Hydrocortisone—NR3C1—skin of body—melanoma	0.000174	0.0209	CbGeAlD
Hydrocortisone—Nausea—Carmustine—melanoma	0.000174	0.0012	CcSEcCtD
Hydrocortisone—ABCG2—mammalian vulva—melanoma	0.000172	0.0207	CbGeAlD
Hydrocortisone—Musculoskeletal discomfort—Docetaxel—melanoma	0.000171	0.00119	CcSEcCtD
Hydrocortisone—Insomnia—Docetaxel—melanoma	0.00017	0.00118	CcSEcCtD
Hydrocortisone—Paraesthesia—Docetaxel—melanoma	0.000169	0.00117	CcSEcCtD
Hydrocortisone—Nausea—Temozolomide—melanoma	0.000168	0.00116	CcSEcCtD
Hydrocortisone—Dyspepsia—Docetaxel—melanoma	0.000165	0.00115	CcSEcCtD
Hydrocortisone—Decreased appetite—Docetaxel—melanoma	0.000163	0.00113	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Docetaxel—melanoma	0.000162	0.00112	CcSEcCtD
Hydrocortisone—Fatigue—Docetaxel—melanoma	0.000162	0.00112	CcSEcCtD
Hydrocortisone—Pain—Docetaxel—melanoma	0.000161	0.00111	CcSEcCtD
Hydrocortisone—NR3C1—mammalian vulva—melanoma	0.000158	0.0191	CbGeAlD
Hydrocortisone—Feeling abnormal—Docetaxel—melanoma	0.000155	0.00107	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Docetaxel—melanoma	0.000154	0.00106	CcSEcCtD
Hydrocortisone—Abdominal pain—Docetaxel—melanoma	0.000148	0.00103	CcSEcCtD
Hydrocortisone—Body temperature increased—Docetaxel—melanoma	0.000148	0.00103	CcSEcCtD
Hydrocortisone—Methylprednisolone—ABCB1—melanoma	0.00014	0.0348	CrCbGaD
Hydrocortisone—Triamcinolone—PTGS2—melanoma	0.000139	0.0345	CrCbGaD
Hydrocortisone—Hypersensitivity—Docetaxel—melanoma	0.000138	0.000959	CcSEcCtD
Hydrocortisone—Asthenia—Docetaxel—melanoma	0.000135	0.000934	CcSEcCtD
Hydrocortisone—Pruritus—Docetaxel—melanoma	0.000133	0.000921	CcSEcCtD
Hydrocortisone—Diarrhoea—Docetaxel—melanoma	0.000128	0.00089	CcSEcCtD
Hydrocortisone—Dizziness—Docetaxel—melanoma	0.000124	0.00086	CcSEcCtD
Hydrocortisone—Vomiting—Docetaxel—melanoma	0.000119	0.000827	CcSEcCtD
Hydrocortisone—Rash—Docetaxel—melanoma	0.000118	0.00082	CcSEcCtD
Hydrocortisone—Dermatitis—Docetaxel—melanoma	0.000118	0.00082	CcSEcCtD
Hydrocortisone—Headache—Docetaxel—melanoma	0.000118	0.000815	CcSEcCtD
Hydrocortisone—Betamethasone—PTGS2—melanoma	0.000113	0.0283	CrCbGaD
Hydrocortisone—Spironolactone—ABCB1—melanoma	0.000113	0.0282	CrCbGaD
Hydrocortisone—NR3C1—head—melanoma	0.000113	0.0137	CbGeAlD
Hydrocortisone—Prednisone—ALB—melanoma	0.000112	0.0279	CrCbGaD
Hydrocortisone—Nausea—Docetaxel—melanoma	0.000112	0.000773	CcSEcCtD
Hydrocortisone—Norethindrone—ALB—melanoma	0.00011	0.0275	CrCbGaD
Hydrocortisone—Prednisone—ABCB1—melanoma	0.000107	0.0266	CrCbGaD
Hydrocortisone—ABCB1—retina—melanoma	0.000106	0.0128	CbGeAlD
Hydrocortisone—Norethindrone—ABCB1—melanoma	0.000105	0.0262	CrCbGaD
Hydrocortisone—Methyltestosterone—ALB—melanoma	0.000105	0.0261	CrCbGaD
Hydrocortisone—Prednisolone—ABCB1—melanoma	9.85e-05	0.0245	CrCbGaD
Hydrocortisone—Betamethasone—ABCB1—melanoma	9.65e-05	0.024	CrCbGaD
Hydrocortisone—ABCG2—lymph node—melanoma	8.61e-05	0.0104	CbGeAlD
Hydrocortisone—ABCB1—mammalian vulva—melanoma	8.47e-05	0.0102	CbGeAlD
Hydrocortisone—NR3C1—lymph node—melanoma	7.93e-05	0.00956	CbGeAlD
Hydrocortisone—Dexamethasone—PTGS2—melanoma	6.6e-05	0.0164	CrCbGaD
Hydrocortisone—Progesterone—ABCB1—melanoma	6.14e-05	0.0153	CrCbGaD
Hydrocortisone—Testosterone—ALB—melanoma	6.08e-05	0.0151	CrCbGaD
Hydrocortisone—ABCB1—head—melanoma	6.06e-05	0.00731	CbGeAlD
Hydrocortisone—Testosterone—ABCB1—melanoma	5.8e-05	0.0144	CrCbGaD
Hydrocortisone—Dexamethasone—ABCB1—melanoma	5.61e-05	0.014	CrCbGaD
Hydrocortisone—ABCB1—lymph node—melanoma	4.25e-05	0.00512	CbGeAlD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.83e-05	0.000123	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—PIK3CA—melanoma	1.82e-05	0.000123	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	1.81e-05	0.000122	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—HPSE—melanoma	1.81e-05	0.000122	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—MDM2—melanoma	1.81e-05	0.000122	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—MTAP—melanoma	1.81e-05	0.000122	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	1.81e-05	0.000122	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—ERBB2—melanoma	1.79e-05	0.00012	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CUBN—melanoma	1.78e-05	0.00012	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PIK3CD—melanoma	1.78e-05	0.00012	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	1.77e-05	0.000119	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—PIK3CB—melanoma	1.76e-05	0.000119	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—ALB—melanoma	1.75e-05	0.000118	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PIK3CG—melanoma	1.74e-05	0.000117	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—CYP17A1—melanoma	1.73e-05	0.000117	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—UGT2B10—melanoma	1.73e-05	0.000116	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	1.72e-05	0.000116	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—SDHD—melanoma	1.72e-05	0.000116	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—BSG—melanoma	1.72e-05	0.000116	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CSPG4—melanoma	1.72e-05	0.000116	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—CYP17A1—melanoma	1.71e-05	0.000115	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	1.71e-05	0.000115	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CXCL8—melanoma	1.69e-05	0.000114	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—HRAS—melanoma	1.68e-05	0.000113	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PPARG—melanoma	1.68e-05	0.000113	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	1.67e-05	0.000112	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GPAM—melanoma	1.67e-05	0.000112	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	1.66e-05	0.000112	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	1.66e-05	0.000112	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CDKN1B—melanoma	1.65e-05	0.000111	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—AKT1—melanoma	1.64e-05	0.00011	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PLA2G6—melanoma	1.63e-05	0.00011	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—GNA11—melanoma	1.63e-05	0.00011	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.62e-05	0.000109	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CASP3—melanoma	1.62e-05	0.000109	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—IL2—melanoma	1.62e-05	0.000109	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—GNA11—melanoma	1.62e-05	0.000109	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—LUM—melanoma	1.61e-05	0.000109	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PHGDH—melanoma	1.61e-05	0.000109	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—IL6—melanoma	1.61e-05	0.000109	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—HS3ST5—melanoma	1.61e-05	0.000108	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—ALB—melanoma	1.6e-05	0.000108	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—FASN—melanoma	1.6e-05	0.000108	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—CDKN2B—melanoma	1.59e-05	0.000107	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—FASN—melanoma	1.58e-05	0.000107	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—HPSE—melanoma	1.58e-05	0.000106	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CCND1—melanoma	1.58e-05	0.000106	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—SLC5A5—melanoma	1.57e-05	0.000106	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CTNNB1—melanoma	1.56e-05	0.000105	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—SLC5A5—melanoma	1.56e-05	0.000105	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CUBN—melanoma	1.55e-05	0.000105	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—VDR—melanoma	1.55e-05	0.000104	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PIK3CB—melanoma	1.55e-05	0.000104	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PTGS2—melanoma	1.53e-05	0.000103	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—MMP9—melanoma	1.53e-05	0.000103	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PIK3CD—melanoma	1.53e-05	0.000103	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CDKN1A—melanoma	1.53e-05	0.000103	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—PTEN—melanoma	1.52e-05	0.000103	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—GNAQ—melanoma	1.52e-05	0.000102	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—CD44—melanoma	1.52e-05	0.000102	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—NFKB1—melanoma	1.52e-05	0.000102	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—ABCB1—melanoma	1.51e-05	0.000102	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—ALB—melanoma	1.51e-05	0.000102	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—GNAQ—melanoma	1.5e-05	0.000101	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—CD44—melanoma	1.5e-05	0.000101	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.5e-05	0.000101	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—BSG—melanoma	1.5e-05	0.000101	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CSPG4—melanoma	1.5e-05	0.000101	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—SDHD—melanoma	1.5e-05	0.000101	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—AKT1—melanoma	1.49e-05	0.0001	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—VCAN—melanoma	1.47e-05	9.89e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—CYP1B1—melanoma	1.46e-05	9.81e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GPAM—melanoma	1.45e-05	9.78e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—CYP1B1—melanoma	1.44e-05	9.72e-05	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—PRKCA—melanoma	1.43e-05	9.62e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.42e-05	9.58e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PLA2G6—melanoma	1.42e-05	9.54e-05	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—ERCC2—melanoma	1.42e-05	9.54e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PRKCA—melanoma	1.39e-05	9.39e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.38e-05	9.31e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—ERCC2—melanoma	1.38e-05	9.31e-05	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—VEGFA—melanoma	1.38e-05	9.27e-05	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—STAT3—melanoma	1.36e-05	9.18e-05	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—NRAS—melanoma	1.36e-05	9.16e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.35e-05	9.11e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.35e-05	9.11e-05	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PTEN—melanoma	1.34e-05	9.01e-05	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PIK3CB—melanoma	1.33e-05	8.99e-05	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PTGS2—melanoma	1.32e-05	8.9e-05	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—MAPK3—melanoma	1.3e-05	8.77e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.29e-05	8.68e-05	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—MYC—melanoma	1.28e-05	8.61e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.28e-05	8.61e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—VCAN—melanoma	1.27e-05	8.57e-05	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—MYC—melanoma	1.27e-05	8.53e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CYP17A1—melanoma	1.24e-05	8.35e-05	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—MAPK1—melanoma	1.24e-05	8.34e-05	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—EGFR—melanoma	1.24e-05	8.34e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PLA2G6—melanoma	1.23e-05	8.31e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PLCB4—melanoma	1.22e-05	8.21e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.2e-05	8.11e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—ABCB1—melanoma	1.2e-05	8.08e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—ABCB1—melanoma	1.19e-05	8.01e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.17e-05	7.91e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GNA11—melanoma	1.17e-05	7.88e-05	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—KRAS—melanoma	1.17e-05	7.88e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.16e-05	7.83e-05	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PTEN—melanoma	1.15e-05	7.76e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PIP4K2A—melanoma	1.14e-05	7.72e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—SLC6A11—melanoma	1.14e-05	7.72e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—FASN—melanoma	1.14e-05	7.72e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.14e-05	7.71e-05	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—NOTCH1—melanoma	1.14e-05	7.7e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.13e-05	7.65e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—SLC5A5—melanoma	1.13e-05	7.59e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—MTAP—melanoma	1.11e-05	7.51e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—VCAN—melanoma	1.11e-05	7.47e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PRKCA—melanoma	1.1e-05	7.43e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—ERCC2—melanoma	1.09e-05	7.37e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PRKCA—melanoma	1.09e-05	7.37e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PIK3CG—melanoma	1.09e-05	7.35e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GNAQ—melanoma	1.09e-05	7.33e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CD44—melanoma	1.09e-05	7.33e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—ERCC2—melanoma	1.08e-05	7.31e-05	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—PPARG—melanoma	1.08e-05	7.27e-05	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—PIK3CA—melanoma	1.07e-05	7.24e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CYP17A1—melanoma	1.07e-05	7.23e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.06e-05	7.13e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PPARG—melanoma	1.05e-05	7.1e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	1.04e-05	7.04e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CYP1B1—melanoma	1.04e-05	7.03e-05	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—TP53—melanoma	1.04e-05	7e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GNA11—melanoma	1.01e-05	6.83e-05	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—HRAS—melanoma	9.94e-06	6.7e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—LUM—melanoma	9.93e-06	6.69e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PHGDH—melanoma	9.93e-06	6.69e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—FASN—melanoma	9.92e-06	6.68e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—SLC5A5—melanoma	9.75e-06	6.57e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—HPSE—melanoma	9.73e-06	6.56e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PIK3CD—melanoma	9.59e-06	6.46e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	9.58e-06	6.46e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CUBN—melanoma	9.56e-06	6.44e-05	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—IL6—melanoma	9.51e-06	6.41e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—ALB—melanoma	9.47e-06	6.38e-05	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PIK3CA—melanoma	9.43e-06	6.36e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GNAQ—melanoma	9.42e-06	6.35e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CD44—melanoma	9.42e-06	6.35e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CYP17A1—melanoma	9.35e-06	6.3e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CSPG4—melanoma	9.23e-06	6.22e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—SDHD—melanoma	9.23e-06	6.22e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—BSG—melanoma	9.23e-06	6.22e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	9.22e-06	6.22e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.14e-06	6.16e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CYP1B1—melanoma	9.03e-06	6.09e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GPAM—melanoma	8.94e-06	6.02e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GNA11—melanoma	8.83e-06	5.95e-05	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—AKT1—melanoma	8.78e-06	5.92e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	8.65e-06	5.83e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—FASN—melanoma	8.64e-06	5.82e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PIK3CG—melanoma	8.64e-06	5.82e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ABCB1—melanoma	8.59e-06	5.79e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PIK3CG—melanoma	8.56e-06	5.77e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—SLC5A5—melanoma	8.5e-06	5.73e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PIK3CB—melanoma	8.36e-06	5.63e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PPARG—melanoma	8.34e-06	5.62e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PTGS2—melanoma	8.28e-06	5.58e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PPARG—melanoma	8.26e-06	5.57e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GNAQ—melanoma	8.21e-06	5.53e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CD44—melanoma	8.21e-06	5.53e-05	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PIK3CA—melanoma	8.13e-06	5.48e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.97e-06	5.37e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PRKCA—melanoma	7.9e-06	5.33e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CYP1B1—melanoma	7.87e-06	5.3e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ERCC2—melanoma	7.84e-06	5.28e-05	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—AKT1—melanoma	7.7e-06	5.19e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PLA2G6—melanoma	7.6e-06	5.12e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PIK3CD—melanoma	7.59e-06	5.12e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PIK3CD—melanoma	7.53e-06	5.07e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—ALB—melanoma	7.5e-06	5.05e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ABCB1—melanoma	7.44e-06	5.01e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—ALB—melanoma	7.43e-06	5.01e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PTEN—melanoma	7.22e-06	4.87e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PRKCA—melanoma	6.84e-06	4.61e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—VCAN—melanoma	6.83e-06	4.6e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ERCC2—melanoma	6.79e-06	4.57e-05	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—AKT1—melanoma	6.64e-06	4.47e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PIK3CB—melanoma	6.62e-06	4.46e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PIK3CB—melanoma	6.56e-06	4.42e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PTGS2—melanoma	6.56e-06	4.42e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PTGS2—melanoma	6.5e-06	4.38e-05	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—MAPK3—melanoma	6.33e-06	4.26e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PIK3CG—melanoma	6.19e-06	4.17e-05	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—MYC—melanoma	6.15e-06	4.15e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PPARG—melanoma	5.97e-06	4.03e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PRKCA—melanoma	5.96e-06	4.02e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—ERCC2—melanoma	5.91e-06	3.99e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CYP17A1—melanoma	5.76e-06	3.88e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PTEN—melanoma	5.72e-06	3.85e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PTEN—melanoma	5.67e-06	3.82e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.62e-06	3.79e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PIK3CD—melanoma	5.44e-06	3.67e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GNA11—melanoma	5.44e-06	3.67e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ALB—melanoma	5.37e-06	3.62e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PIK3CG—melanoma	5.36e-06	3.61e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—FASN—melanoma	5.32e-06	3.59e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—SLC5A5—melanoma	5.24e-06	3.53e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PPARG—melanoma	5.17e-06	3.49e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PIK3CA—melanoma	5.1e-06	3.43e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GNAQ—melanoma	5.06e-06	3.41e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CD44—melanoma	5.06e-06	3.41e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CYP1B1—melanoma	4.85e-06	3.27e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PIK3CB—melanoma	4.74e-06	3.2e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PIK3CD—melanoma	4.71e-06	3.18e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PTGS2—melanoma	4.7e-06	3.17e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PIK3CG—melanoma	4.67e-06	3.15e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ALB—melanoma	4.65e-06	3.14e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PPARG—melanoma	4.51e-06	3.04e-05	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—AKT1—melanoma	4.27e-06	2.88e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—AKT1—melanoma	4.16e-06	2.81e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PIK3CB—melanoma	4.11e-06	2.77e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PIK3CD—melanoma	4.11e-06	2.77e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PTEN—melanoma	4.1e-06	2.76e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PTGS2—melanoma	4.07e-06	2.74e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—ALB—melanoma	4.05e-06	2.73e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PIK3CA—melanoma	4.04e-06	2.72e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PIK3CA—melanoma	4e-06	2.7e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ABCB1—melanoma	3.99e-06	2.69e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PRKCA—melanoma	3.67e-06	2.48e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ERCC2—melanoma	3.64e-06	2.46e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PIK3CB—melanoma	3.58e-06	2.41e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PTEN—melanoma	3.55e-06	2.39e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PTGS2—melanoma	3.55e-06	2.39e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—AKT1—melanoma	3.3e-06	2.22e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—AKT1—melanoma	3.27e-06	2.2e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PTEN—melanoma	3.09e-06	2.08e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PIK3CA—melanoma	2.89e-06	1.95e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PIK3CG—melanoma	2.88e-06	1.94e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PPARG—melanoma	2.78e-06	1.87e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PIK3CD—melanoma	2.53e-06	1.7e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PIK3CA—melanoma	2.5e-06	1.69e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ALB—melanoma	2.5e-06	1.68e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—AKT1—melanoma	2.36e-06	1.59e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PIK3CB—melanoma	2.21e-06	1.49e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PTGS2—melanoma	2.18e-06	1.47e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PIK3CA—melanoma	2.18e-06	1.47e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—AKT1—melanoma	2.05e-06	1.38e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PTEN—melanoma	1.91e-06	1.28e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—AKT1—melanoma	1.78e-06	1.2e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PIK3CA—melanoma	1.34e-06	9.06e-06	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—AKT1—melanoma	1.1e-06	7.4e-06	CbGpPWpGaD
